Skip to main content

Qube Research & Technologies Ltd

SEC CIK
0001729829
Latest filing
Aug 14, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of ABBV by Qube Research & Technologies Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−1,093,561−100.0%Sold outHolders
Q4 20251,093,561$249.9M0.4%−489,743−30.9%ReducedHolders
Q3 20251,583,304$366.6M0.5%−1,830,775−53.6%ReducedHolders
Q2 20253,414,079$633.7M0.9%+1,281,601+60.1%AddedHolders
Q1 20252,132,478$446.8M0.7%+1,343,860+170.4%AddedHolders
Q4 2024788,618$140.1M0.2%−280,621−26.2%ReducedHolders
Q3 20241,069,239$211.2M0.4%+328,701+44.4%AddedHolders
Q2 2024740,538$127.0M0.2%−543,423−42.3%ReducedHolders
Q1 20241,283,961$233.8M0.4%+89,165+7.5%AddedHolders
Q4 20231,194,796$185.2M0.4%+841,342+238.0%AddedHolders
Q3 2023353,454$52.7M0.2%−555,882−61.1%ReducedHolders
Q2 2023909,336$122.5M0.5%+909,336NewHolders
Q1 20230$00.0%−118,876−100.0%Sold outHolders
Q4 2022118,876$19.2M0.1%+114,346+2,524.2%AddedHolders
Q3 20224,530$608.0K<0.1%−22,708−83.4%ReducedHolders
Q2 202227,238$4.17M<0.1%+20,238+289.1%AddedHolders
Q1 20227,000$1.14M<0.1%+7,000NewHolders
Q4 20210$00.0%−2,072−100.0%Sold outHolders
Q3 20212,072$224.0K<0.1%−226,548−99.1%ReducedHolders
Q2 2021228,620$25.8M0.3%+198,619+662.0%AddedHolders
Q1 202130,001$3.25M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.